James Fitzpatrick

James Fitzpatrick is a strategic leader in the field of cellular imaging, currently serving as the Global Head of pRED 360 Labs at Roche, where they work to facilitate integrated research innovation. Previously, they held roles such as Director and Senior Staff Scientist at the Salk Institute for Biological Studies and Professor at Washington University School of Medicine in St. Louis, leading significant initiatives in advanced imaging and research. James earned a BSc in Chemistry from King’s College London, followed by a PhD in Chemical and Optical Physics from the University of Bristol, and completed post-doctoral research at both the University of Pittsburgh and Carnegie Mellon University.